中文名：BG45
英文名：BG45
英文別名：BG45|926259-99-6|N-(2-aminophenyl)pyrazine-2-carboxamide|BG-45|N-(2-Aminophenyl)-2-pyrazinecarboxamide|12P6IK4ZUX|UNII-12P6IK4ZUX|2-Pyrazinecarboxamide, N-(2-aminophenyl)-|CHEMBL4283263|BG45, HDAC3 Inhibitor|SCHEMBL18064956|CHEBI:125522|LMWPVSNHKACEKW-UHF
純度：97%
貨號(hào)：B413814
包裝：10mg、200mg、50mg
Cas號(hào)：926259-99-6
存儲(chǔ)溫度：-20°C儲(chǔ)存
產(chǎn)品介紹：
Information
BG45 is a class IHDACinhibitor withIC50of 289 nM, 2.0 μM, 2.2 μM and >20 μM for HDAC3, HDAC1, HDAC2, and HDAC6 in cell-free assays, respectively.
Targets
HDAC3 ; HDAC1 ; HDAC2 289 nM; 2 μM; 2.2 μM
In vitro
BG45 causes significant cell growth inhibition and induces caspase-dependent apoptosis in a series of MM cells. In RPMI8226 cells, BG45 synergistically enhances bortezomib-induced cytotoxicity.
In vivo
In mice bearing MM.1S xenograft of human MM, BG45 (50 mg/kg, i.p.) significantly inhibits MM tumor growth. When in combination with bortezomib, BG45 (50 mg/kg, i.p.) enhances bortezomib-induced cytotoxicity.
Cell Research(from reference)
Cell lines：MM.1S, RPMI8226, U266, H929, MM.1\u2009R, RPMI-LR5, OPM1, OPM2 and RPMI-DOX40 cells?
Concentrations：~30 μM?
Incubation Time：48 h?
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對(duì)應(yīng)頁(yè)面：https://www.aladdin-e.com/zh_cn/B413814.html
關(guān)鍵字： BG45;926259-99-6;N-(2-aminophenyl)pyrazine-2-carboxamide;BG-45
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代碼：688179），專注于科研試劑的研發(fā)、生產(chǎn)和銷售，已陸續(xù)建立多個(gè)工廠和研發(fā)中心。作為領(lǐng)軍企業(yè)，阿拉丁始終堅(jiān)持質(zhì)量第一，連續(xù)13年被評(píng)為“最受歡迎試劑品牌”。
阿拉丁目前常備庫(kù)存試劑產(chǎn)品品種超過(guò)7萬(wàn)種，SKU總數(shù)超過(guò)46萬(wàn)，產(chǎn)品線涵蓋了化學(xué)試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個(gè)領(lǐng)域，是國(guó)內(nèi)少數(shù)化學(xué)試劑到生物試劑全面發(fā)展的國(guó)產(chǎn)試劑品牌，產(chǎn)品同步發(fā)布在我們國(guó)內(nèi)外電商平臺(tái)。